ZURLO, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 428
AS - Asia 213
EU - Europa 154
AF - Africa 1
SA - Sud America 1
Totale 797
Nazione #
US - Stati Uniti d'America 418
SG - Singapore 99
IT - Italia 76
CN - Cina 68
ID - Indonesia 36
DE - Germania 24
GB - Regno Unito 15
CA - Canada 10
SE - Svezia 7
FI - Finlandia 6
CZ - Repubblica Ceca 5
PL - Polonia 5
HK - Hong Kong 4
IN - India 4
NL - Olanda 4
BE - Belgio 3
LT - Lituania 3
CH - Svizzera 2
FR - Francia 2
BR - Brasile 1
EG - Egitto 1
ES - Italia 1
KR - Corea 1
RO - Romania 1
VN - Vietnam 1
Totale 797
Città #
Santa Clara 95
Singapore 81
Ashburn 58
Chandler 47
Jakarta 36
Shanghai 29
Fairfield 23
Ferrara 22
Milan 21
Bremen 13
Wilmington 12
Beijing 11
Ferrara di Monte Baldo 10
Addison 9
Houston 9
Washington 9
Los Angeles 8
Princeton 8
Bologna 6
Frankfurt am Main 6
London 6
San Diego 6
Cambridge 5
Munich 5
Ottawa 5
Toronto 5
Woodbridge 5
Brno 4
Hong Kong 4
Rome 4
Warsaw 4
Brussels 3
Helsinki 3
Lappeenranta 3
Seattle 3
Amsterdam 2
Ann Arbor 2
Bern 2
Boardman 2
Chicago 2
Gualtieri 2
Hefei 2
Lucknow 2
New York 2
Piscataway 2
Prescot 2
Southwark 2
Ariano nel Polesine 1
Baricella 1
Cairo 1
Dong Ket 1
Forest City 1
Hounslow 1
Hyderabad 1
Islington 1
Jiangmen 1
Jinan 1
Jiujiang 1
Kaifeng 1
Langfang 1
Madrid 1
Monselice 1
Naples 1
North Bergen 1
Prague 1
Redmond 1
Reggio Emilia 1
Taicang 1
Verona 1
Totale 624
Nome #
Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology 76
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 67
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 59
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p 57
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 48
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 47
Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis 37
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 35
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 34
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 33
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 32
Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective 32
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 31
Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold 31
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 25
Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis 24
MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines 24
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 24
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 20
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 18
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm' 17
Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics 16
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 16
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 15
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 14
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 14
Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management 13
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p 12
Totale 871
Categoria #
all - tutte 9.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 2 2 3 12 2 2
2020/202132 2 2 2 5 0 5 0 1 3 8 1 3
2021/202276 4 1 16 0 5 2 5 5 10 1 8 19
2022/2023169 12 18 4 8 27 6 42 12 20 2 10 8
2023/2024220 5 21 16 8 23 42 17 31 6 2 6 43
2024/2025345 35 34 69 51 96 60 0 0 0 0 0 0
Totale 871